Cargando…

THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION

The response of rhesus monkeys to a subcutaneous inoculation with varying amounts of virus modified by prolonged cultivation in vitro has been studied. The tissue components of the medium consisted of chick embryo tissue containing minimal amounts of nervous tissue. The immunity produced in monkeys,...

Descripción completa

Detalles Bibliográficos
Autores principales: Theiler, Max, Smith, Hugh H.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1937
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133527/
https://www.ncbi.nlm.nih.gov/pubmed/19870634
_version_ 1782142690213756928
author Theiler, Max
Smith, Hugh H.
author_facet Theiler, Max
Smith, Hugh H.
author_sort Theiler, Max
collection PubMed
description The response of rhesus monkeys to a subcutaneous inoculation with varying amounts of virus modified by prolonged cultivation in vitro has been studied. The tissue components of the medium consisted of chick embryo tissue containing minimal amounts of nervous tissue. The immunity produced in monkeys, as measured by the antibody titer developed, has no relation to the amount of virus inoculated. Monkeys inoculated subcutaneously with the tissue culture virus are rendered immune to a subsequent injection of a highly virulent yellow fever virus. This resistance is already present 7 days after vaccination. The subcutaneous inoculation of the culture virus into immune persons leads to a substantial increase of the serum antibody titer. The results of vaccinating eight normal persons with culture virus are presented. The reactions were minimal. The highest temperature recorded following vaccination was 37.4°C. The sera taken from the eight vaccinated persons 2 to 4 weeks after inoculation with the tissue culture virus showed the presence of yellow fever antibodies.
format Text
id pubmed-2133527
institution National Center for Biotechnology Information
language English
publishDate 1937
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21335272008-04-18 THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION Theiler, Max Smith, Hugh H. J Exp Med Article The response of rhesus monkeys to a subcutaneous inoculation with varying amounts of virus modified by prolonged cultivation in vitro has been studied. The tissue components of the medium consisted of chick embryo tissue containing minimal amounts of nervous tissue. The immunity produced in monkeys, as measured by the antibody titer developed, has no relation to the amount of virus inoculated. Monkeys inoculated subcutaneously with the tissue culture virus are rendered immune to a subsequent injection of a highly virulent yellow fever virus. This resistance is already present 7 days after vaccination. The subcutaneous inoculation of the culture virus into immune persons leads to a substantial increase of the serum antibody titer. The results of vaccinating eight normal persons with culture virus are presented. The reactions were minimal. The highest temperature recorded following vaccination was 37.4°C. The sera taken from the eight vaccinated persons 2 to 4 weeks after inoculation with the tissue culture virus showed the presence of yellow fever antibodies. The Rockefeller University Press 1937-05-31 /pmc/articles/PMC2133527/ /pubmed/19870634 Text en Copyright © Copyright, 1937, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Theiler, Max
Smith, Hugh H.
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title_full THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title_fullStr THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title_full_unstemmed THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title_short THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
title_sort use of yellow fever virus modified by in vitro cultivation for human immunization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133527/
https://www.ncbi.nlm.nih.gov/pubmed/19870634
work_keys_str_mv AT theilermax theuseofyellowfevervirusmodifiedbyinvitrocultivationforhumanimmunization
AT smithhughh theuseofyellowfevervirusmodifiedbyinvitrocultivationforhumanimmunization
AT theilermax useofyellowfevervirusmodifiedbyinvitrocultivationforhumanimmunization
AT smithhughh useofyellowfevervirusmodifiedbyinvitrocultivationforhumanimmunization